Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK/NF-κB signaling pathway

Zhichao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Honggang Zhou(Nankai University)

Research Square

February 21, 2024

10.21203/rs.3.rs-3921405/v1

Cited by 0

Related Papers

Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: prospective multicentre preSINO trial

|British journal of surgery|2025|11

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis

|Research Square|2021|4

Alleviated T cell exhaustion and SLC1A3-mediated stroma-remodelling dictate chemoimmunotherapy efficacy in oesophageal squamous cell carcinoma

|Gut|2025|2

Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway

|Biomolecules|2025|1